Anthera Pharmaceuticals Inc Stock Nasdaq
Equities
US03674U2015
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
2018 | Anthera Pharmaceuticals, Inc.(OTCPK:ANTH) dropped from S&P TMI Index | CI |
2018 | Anthera Pharmaceuticals, Inc.(OTCPK:ANTH) dropped from NASDAQ Composite Index | CI |
Financials (USD)
Sales 2016 | 0.14 | Sales 2017 | - | Capitalization | 22.85M |
---|---|---|---|---|---|
Net income 2016 | -55M | Net income 2017 | -26M | EV / Sales 2016 | 44,069,434 x |
Net cash position 2016 | 20.84M | Net cash position 2017 | 2.2M | EV / Sales 2017 | - |
P/E ratio 2016 |
-0.4
x | P/E ratio 2017 |
-0.58
x | Employees | - |
Yield 2016 * |
-
| Yield 2017 |
-
| Free-Float | 100% |
1st Jan change | Capi. | |
---|---|---|
+2.49% | 96.73B | |
-0.47% | 21.31B | |
-16.61% | 21.21B | |
-5.01% | 18.79B | |
-42.14% | 16.37B | |
-27.40% | 13.68B | |
+1.44% | 13.44B | |
+21.29% | 10.98B | |
-21.79% | 8.56B |